Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Paraneoplastic Syndromes

technetium tc 99m sestamibi has been researched along with Paraneoplastic Syndromes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchpiguel, CA; Correa, PH; Ferraz, MP; Martin, RM; Ono, CR; Sado, HN; Watanabe, T1
Kimizuka, T; Ozaki, Y; Sumi, Y1
Nguyen, BD1

Other Studies

3 other study(ies) available for technetium tc 99m sestamibi and Paraneoplastic Syndromes

ArticleYear
Concordance between whole-body scintigraphy 111In-octreotide and 99mTc-sestamibi uptake in the detection of four tumor-induced osteomalacia cases.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Neoplasms; Octreotide; Osteomalacia; Paraneoplastic Syndromes; Radionuclide Imaging; Reproducibility of Results; Technetium Tc 99m Sestamibi; Whole Body Imaging; Young Adult

2014
Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia.
    Annals of nuclear medicine, 2004, Volume: 18, Issue:1

    Topics: Hemangiopericytoma; Humans; Knee Joint; Male; Middle Aged; Neoplasms, Adipose Tissue; Osteomalacia; Paraneoplastic Syndromes; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium

2004
Coexisting hyperparathyroidism and oncogenic osteomalacia: Sestamibi and somatostatin receptor scintigraphy.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:10

    Topics: Humans; Hyperparathyroidism; Male; Middle Aged; Octreotide; Osteomalacia; Paraneoplastic Syndromes; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2006